STOCK TITAN

Life365 Appoints Healthcare Veteran Jay Roberts as Chief Development Officer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management

Life365 has appointed healthcare veteran Jay Roberts as Chief Development Officer to drive strategic growth and partnerships. Roberts, who previously served as an executive advisor to Life365, brings over 30 years of healthcare leadership experience to the role. In his new position, he will focus on securing funding, building strategic partnerships, and fostering stakeholder relationships to accelerate market expansion.

Roberts currently serves as a partner with Ventac Partners and as a venture partner for DigiLife Fund II. His extensive experience includes CEO, COO, and CFO positions at Nasdaq-traded companies, involvement in over 50 M&A and financing transactions, and board positions at various healthcare companies including Cingulate (CING). He previously served as president and CEO of Vyant Bio and held leadership roles at Cancer Genetics and VirMedica.

Life365 ha nominato il veterano del settore sanitario Jay Roberts come Chief Development Officer per guidare la crescita strategica e le partnership. Roberts, che in precedenza ha ricoperto il ruolo di consulente esecutivo per Life365, porta con sé oltre 30 anni di esperienza nella leadership sanitaria. Nel suo nuovo incarico, si concentrerà sull'ottenimento di finanziamenti, sulla costruzione di partnership strategiche e sul rafforzamento delle relazioni con gli stakeholder per accelerare l'espansione sul mercato.

Attualmente Roberts è partner di Ventac Partners e venture partner per DigiLife Fund II. La sua vasta esperienza comprende ruoli di CEO, COO e CFO in società quotate al Nasdaq, la partecipazione a oltre 50 operazioni di M&A e finanziamenti, oltre a posizioni nel consiglio di amministrazione di diverse aziende sanitarie, tra cui Cingulate (CING). In precedenza è stato presidente e CEO di Vyant Bio e ha ricoperto ruoli di leadership in Cancer Genetics e VirMedica.

Life365 ha nombrado al veterano del sector sanitario Jay Roberts como Chief Development Officer para impulsar el crecimiento estratégico y las asociaciones. Roberts, quien anteriormente fue asesor ejecutivo de Life365, aporta más de 30 años de experiencia en liderazgo sanitario. En su nuevo cargo, se enfocará en asegurar financiamiento, construir alianzas estratégicas y fomentar relaciones con los interesados para acelerar la expansión en el mercado.

Actualmente, Roberts es socio de Ventac Partners y socio de riesgo para DigiLife Fund II. Su amplia experiencia incluye cargos de CEO, COO y CFO en empresas cotizadas en Nasdaq, participación en más de 50 transacciones de fusiones, adquisiciones y financiamiento, además de posiciones en juntas directivas de varias compañías del sector salud, incluyendo Cingulate (CING). Anteriormente fue presidente y CEO de Vyant Bio y tuvo roles de liderazgo en Cancer Genetics y VirMedica.

Life365는 보건 의료 분야의 베테랑 Jay Roberts를 최고 개발 책임자(Chief Development Officer)로 임명하여 전략적 성장과 파트너십을 추진합니다. Roberts는 이전에 Life365의 경영 고문으로 활동했으며, 30년 이상의 보건 의료 리더십 경험을 보유하고 있습니다. 새로운 직책에서 그는 자금 확보, 전략적 파트너십 구축, 이해관계자 관계 강화에 집중하여 시장 확장을 가속화할 예정입니다.

Roberts는 현재 Ventac Partners의 파트너이자 DigiLife Fund II의 벤처 파트너로 활동 중입니다. 그의 폭넓은 경험에는 나스닥 상장 기업에서 CEO, COO, CFO 직책 수행, 50건 이상의 인수합병 및 자금 조달 거래 참여, 그리고 Cingulate(CING)를 포함한 여러 보건 의료 기업의 이사회 활동이 포함됩니다. 이전에는 Vyant Bio의 사장 겸 CEO를 역임했으며 Cancer Genetics와 VirMedica에서 리더십 역할을 맡았습니다.

Life365 a nommé le vétéran du secteur de la santé Jay Roberts au poste de Chief Development Officer afin de stimuler la croissance stratégique et les partenariats. Roberts, qui a auparavant été conseiller exécutif pour Life365, apporte plus de 30 ans d'expérience en leadership dans le domaine de la santé. Dans son nouveau rôle, il se concentrera sur l'obtention de financements, la construction de partenariats stratégiques et le renforcement des relations avec les parties prenantes pour accélérer l'expansion sur le marché.

Roberts est actuellement associé chez Ventac Partners et partenaire en capital-risque pour DigiLife Fund II. Sa vaste expérience inclut des postes de CEO, COO et CFO dans des entreprises cotées au Nasdaq, la participation à plus de 50 opérations de fusions-acquisitions et de financements, ainsi que des sièges au conseil d'administration de plusieurs entreprises de santé, dont Cingulate (CING). Il a précédemment été président et CEO de Vyant Bio et a occupé des postes de direction chez Cancer Genetics et VirMedica.

Life365 hat den erfahrenen Gesundheitswesen-Experten Jay Roberts zum Chief Development Officer ernannt, um das strategische Wachstum und Partnerschaften voranzutreiben. Roberts, der zuvor als Executive Advisor für Life365 tätig war, bringt über 30 Jahre Führungserfahrung im Gesundheitswesen mit. In seiner neuen Position wird er sich auf die Sicherung von Finanzierung, den Aufbau strategischer Partnerschaften und die Pflege von Stakeholder-Beziehungen konzentrieren, um die Marktexpansion zu beschleunigen.

Roberts ist derzeit Partner bei Ventac Partners und Venture Partner beim DigiLife Fund II. Seine umfangreiche Erfahrung umfasst CEO-, COO- und CFO-Positionen bei an der Nasdaq gelisteten Unternehmen, die Beteiligung an über 50 M&A- und Finanzierungs-Transaktionen sowie Vorstandspositionen bei verschiedenen Gesundheitsunternehmen, darunter Cingulate (CING). Zuvor war er Präsident und CEO von Vyant Bio und hatte Führungsrollen bei Cancer Genetics und VirMedica inne.

Positive
  • Appointment of highly experienced executive with 30+ years in healthcare leadership
  • Roberts brings extensive M&A experience with involvement in over 50 transactions
  • Strong network and connections through multiple board positions and venture partnerships
  • Previous familiarity with company as executive advisor indicates smooth transition
Negative
  • None.

Industry Leader with 30+ Years of Experience Will Drive Strategic Growth and Partnerships

SCOTTSDALE, Ariz., May 27, 2025 /PRNewswire/ -- Life365, a leading data engagement and virtual care company, today announced the appointment of healthcare executive and investor Jay Roberts as chief development officer.

Roberts, who previously served as an executive advisor to Life365, brings more than 30 years of strategic healthcare leadership experience to this pivotal role. Life365's platform enables the next generation of AI-driven healthcare for enterprise healthcare organizations, payers, and government entities.

In his new position, Roberts will spearhead the company's strategic growth initiatives, including securing funding, building strategic partnerships, and fostering relationships with key stakeholders to accelerate Life365's market expansion and long-term success.

"We've already benefited tremendously from Jay's strategic insights during his time as an advisor," said Life365 Founder and CEO Kent Dicks. "His deep expertise in healthcare finance and innovation, coupled with his passion for advancing medical technology, will be invaluable as we pursue our mission to safely and cost-effectively connect patients to care from the comfort of their homes."

Roberts expressed enthusiasm about his expanded role: "Life365 stands at the forefront of healthcare innovation, leveraging advanced technologies like AI to extract actionable insights from patient-generated health data. These insights enable more proactive, preventive care models that can transform healthcare delivery. I'm excited to collaborate with Kent and our investors as Life365 revolutionizes remote patient monitoring to personalize care, improve outcomes, and enhance patient engagement across the healthcare ecosystem."

Extensive Healthcare Leadership Experience

Beyond his role at Life365, Roberts serves as a partner with Ventac Partners, a global catalyst in life sciences that creates breakthrough companies, bringing scientific innovation to patients worldwide. He is also a venture partner for DigiLife Fund II, where he leads fundraising, due diligence, and investment decisions alongside DigiLife team members and syndicate investment funds.

Roberts' governance expertise extends to several prominent roles, including membership on the Board of Trustees of U.S. Pharmacopeia and service on the boards of directors for multiple healthcare companies, including Cingulate (Nasdaq: CING), Caidya Research, Veriskin, NaviPoint Health, and Vyant Bio.

Until February 2023, Roberts served as president and CEO of Vyant Bio, an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders.

Throughout his distinguished career, Roberts has held chief executive officer, chief operating officer (COO), and chief financial officer (CFO) positions for Nasdaq publicly traded companies and venture and private equity-backed healthcare technology organizations. His experience spans diagnostics, software solutions, and manufacturing companies, with involvement in more than 50 M&A and debt and equity transactions.

Roberts previously served as CEO and COO of Cancer Genetics. Prior to that, he was CFO for VirMedica, an innovative technology solutions company.

A current member of the Alliance of CEOs, Roberts is recognized as a thought leader and expert panelist for numerous programs and publications on topics, including "conscious capitalism," leadership and mentoring, corporate finance, mergers and acquisitions, capital formation, and healthcare innovation. He holds an MBA from the University of Maine.

About Life365

Life365 is a leading developer of virtual care technology solutions that enable healthcare delivery at home. The Life365 platform addresses key care delivery challenges by providing scalable solution integration and logistics to enterprise healthcare organizations, enabling patient connectivity, engagement, and improved outcomes for diverse patient populations.

The platform serves as a single integration point that enables providers, payers, and other stakeholders to implement a proactive, virtual-first care approach to remotely engage and monitor patients with various conditions and needs, including chronic disease management, post-discharge care, and population health management.

Led by an experienced, industry-recognized team, Life365 is a major patent holder of wearables, sensors, and patches driven by machine learning/AI, driving the next generation of scalable remote patient monitoring. Life365 serves as a strategic partner of Microsoft Cloud for Healthcare and the Veterans Administration, supporting the largest population of veterans in the world.

For more information, visit www.life365.health.

Media Contact:
Kendall Paulsen | Life365
media@life365.health
888-818-2322 x705

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/life365-appoints-healthcare-veteran-jay-roberts-as-chief-development-officer-302464588.html

SOURCE Life365

FAQ

Who is Jay Roberts and what is his new role at Life365?

Jay Roberts is a healthcare executive with over 30 years of experience who has been appointed as Chief Development Officer at Life365. He will lead strategic growth initiatives, secure funding, and build partnerships.

What is Jay Roberts' previous experience in healthcare leadership?

Roberts has served as CEO, COO, and CFO for Nasdaq-traded companies, was president and CEO of Vyant Bio, and has been involved in over 50 M&A and financing transactions. He currently partners with Ventac Partners and DigiLife Fund II.

What boards does Jay Roberts currently serve on?

Roberts serves on the Board of Trustees of U.S. Pharmacopeia and the boards of directors for several healthcare companies including Cingulate (CING), Caidya Research, Veriskin, NaviPoint Health, and Vyant Bio.

What will be Jay Roberts' main responsibilities at Life365?

As Chief Development Officer, Roberts will lead strategic growth initiatives, secure funding, build strategic partnerships, and foster relationships with key stakeholders to accelerate Life365's market expansion.
Cingulate Inc

NASDAQ:CING

CING Rankings

CING Latest News

CING Stock Data

15.37M
4.14M
3.3%
2.82%
3.71%
Biotechnology
Pharmaceutical Preparations
Link
United States
KANSAS CITY